Tue, Sep 30, 2014, 9:05 AM EDT - U.S. Markets open in 25 mins.

Recent

% | $
Quotes you view appear here for quick access.

Raptor Pharmaceuticals Corp. Message Board

daleedwards99 3 posts  |  Last Activity: Sep 26, 2014 9:23 AM Member since: May 16, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • daleedwards99 by daleedwards99 Sep 26, 2014 9:23 AM Flag

    This low float biotech stock which has several catalysts on tap appears ready to head higher after a lengthy development trend. We haven't covered Portage Biotech Inc.(OTCBB: PTGEF) since it first caught our eye. The company is now developing a strong pipeline and it catches our attention as an undervalued play.

  • daleedwards99 by daleedwards99 Sep 26, 2014 9:09 AM Flag

    This low float biotech stock which has several catalysts on tap appears ready to head higher after a lengthy development trend. We haven't covered Portage Biotech Inc.(OTCBB: PTGEF) since it first caught our eye. The company is now developing a strong pipeline and it catches our attention as an undervalued play.

  • daleedwards99 by daleedwards99 Sep 25, 2014 11:01 AM Flag

    some very key progress IMO...and gone virtually unnoticed .....
    May 08 2014 Portage Signs a Collaborative Research and Development Agreement with Yale University
    May 15 2014 Portage signs a collaborative research and development agreement with US National Institute of Health
    July 14 2014 Portage announces successful validation of its new proprietory cell permeable peptide platform technology
    August 6 2014 Portage's Biohaven granted United States patent for glutamate agents in the treatment of mental disorders
    Sept 11 2014 Portage Announces Proposed Private Placement
    Sept 23 2014 Portage Announces New Consultants for its PPL-003 Development Programs

RPTP
10.15Sep 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.